India reported 2,00,739 new Covid-19 cases in the last 24 hours, the biggest single-day spike ever, taking the overall tally to 1,40,74,564, cases on Thursday, according to the Health Ministry data.
India’s daily deaths due to Covid are also rising with 1,038 new deaths reported on Thursday, the second consecutive day with over thousand deaths. This took the overall death toll in the country to 1,73,123.
A total of 93,528 patients recovered in the same time span, taking the number of recoveries to 1,24,29,564 with a recovery rate of 88.31 per cent.
The Health Ministry said that a total of 13,84,549 samples were tested in the last 24 hours.
So far, 26,20,03,415 samples have been tested in the country.
According to the government data, a total of 33,13,848 people were also vaccinated in the same period, taking the total inoculation count to 11,44,93,238.
Here’re some more updates:
*UP Additional Chief Secretary (Health) issues directions on quarantine of migrant workers returning to the state. They will be screened by the district administration and those showing symptoms will be sent to 14 days of home quarantine. 7 days of home quarantine for the asymptomatic ones.
*Congress candidate from Samsherganj in Murshidabad district, Rezaul Haque, passed away at a hospital in Kolkata earlier this morning. He had tested positive for Covid-19. (ANI)
*Weekend curfew is likely to be imposed in Delhi. CM Arvind Kejriwal will likely announce the curfew in the national capital at 1.00 pm. Delhi Wednesday recorded the biggest single-day jump in its COVID-19 tally with 17,282 new cases, while over 100 people died
*Despite steep rise in Covid-19 cases across the country, more than 13.5 lakh devotees turned up at the ghats of Ganga in Haridwar for the third shahi snan during the Kumbh Mela on Wednesday, officials said.
*Attacking the centre, Congress leader Rahul Gandhi said there are no tests, neither beds in hospitals nor vaccine.
*Denmark on Wednesday announced it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects
